Department of Psychiatry and Human Behavior, Alpert Medical School, Brown University, Providence, Rhode Island.
Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, Rhode Island.
Depress Anxiety. 2019 Nov;36(11):1047-1057. doi: 10.1002/da.22952. Epub 2019 Sep 2.
Recent evidence suggests that therapeutic repetitive transcranial magnetic stimulation (TMS) is an effective treatment for pharmacoresistant posttraumatic stress disorder (PTSD) and comorbid major depressive disorder (MDD). We recently demonstrated that response to 5 Hz TMS administered to the dorsolateral prefrontal cortex was predicted by functional connectivity of the medial prefrontal (MPFC) and subgenual anterior cingulate cortex (sgACC). This functionally-defined circuit is a novel target for treatment optimization research, however, our limited knowledge of the structural pathways that underlie this functional predisposition is a barrier to target engagement research.
To investigate underlying structural elements of our previous functional connectivity findings, we submitted pre-TMS diffusion-weighted imaging data from 20 patients with PTSD and MDD to anatomically constrained tract-based probabilistic tractography (FreeSurfer's TRActs Constrained by UnderLying Anatomy). Averaged pathway fractional anisotropy (FA) was extracted from four frontal white matter tracts: the forceps minor, cingulum, anterior thalamic radiations (ATRs), and uncinate fasciculi. Tract FA statistics were treated as explanatory variables in backward regressions testing the relationship between tract integrity and functional connectivity coefficients from MPFC and sgACC predictors of symptom improvement after TMS.
FA in the ATRs was consistently associated with symptom improvement in PTSD and MDD (Bonferroni-corrected p < .05).
We found that structural characteristics of the ATR account for significant variance in individual-level functional predictors of post-TMS improvement. TMS optimization studies should target this circuit either in stand-alone or successive TMS stimulation protocols.
最近的证据表明,治疗性重复经颅磁刺激(TMS)是治疗耐药性创伤后应激障碍(PTSD)和共病重度抑郁症(MDD)的有效方法。我们最近表明,背外侧前额叶皮层接受 5HzTMS 治疗的反应可以通过内侧前额叶(MPFC)和扣带前回(sgACC)的功能连接来预测。这个功能定义的回路是治疗优化研究的一个新目标,然而,我们对构成这种功能倾向的结构途径的有限了解是靶向研究的一个障碍。
为了研究我们之前功能连接发现的潜在结构元素,我们将 20 名 PTSD 和 MDD 患者的预 TMS 弥散加权成像数据提交给解剖约束束路径概率追踪(FreeSurfer 的 TRActs Constrained by UnderLying Anatomy)。从四个额白质束中提取平均路径各向异性分数(FA):小钳、扣带束、前丘脑辐射(ATR)和钩束。将束 FA 统计数据作为解释变量,用于后向回归测试,以检验束完整性与 MPFC 和 sgACC 预测因子之间的关系,这些预测因子与 TMS 治疗后症状改善的功能连接系数有关。
ATR 的 FA 与 PTSD 和 MDD 的症状改善始终相关(Bonferroni 校正后的 p < 0.05)。
我们发现,ATR 的结构特征解释了 TMS 治疗后改善的个体水平功能预测因子的显著差异。TMS 优化研究应针对该回路进行独立或连续 TMS 刺激方案。